Leavell Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$276K Buy
3,526
+53
+2% +$4.15K 0.01% 504
2025
Q1
$252K Hold
3,473
0.01% 491
2024
Q4
$257K Sell
3,473
-6,450
-65% -$477K 0.01% 485
2024
Q3
$655K Buy
9,923
+321
+3% +$21.2K 0.03% 344
2024
Q2
$887K Hold
9,602
0.05% 285
2024
Q1
$918K Buy
9,602
+258
+3% +$24.7K 0.05% 278
2023
Q4
$712K Hold
9,344
0.05% 295
2023
Q3
$647K Buy
9,344
+40
+0.4% +$2.77K 0.05% 304
2023
Q2
$878K Hold
9,304
0.06% 268
2023
Q1
$770K Hold
9,304
0.05% 278
2022
Q4
$694K Hold
9,304
0.05% 283
2022
Q3
$769K Sell
9,304
-400
-4% -$33.1K 0.06% 260
2022
Q2
$923K Hold
9,704
0.07% 235
2022
Q1
$1.14M Hold
9,704
0.08% 221
2021
Q4
$1.26M Hold
9,704
0.08% 212
2021
Q3
$1.1M Hold
9,704
0.08% 208
2021
Q2
$812K Hold
9,704
0.07% 229
2021
Q1
$812K Sell
9,704
-296
-3% -$24.8K 0.07% 229
2020
Q4
$912K Hold
10,000
0.08% 203
2020
Q3
$798K Hold
10,000
0.07% 208
2020
Q2
$691K Buy
10,000
+400
+4% +$27.6K 0.07% 215
2020
Q1
$604K Buy
9,600
+4,800
+100% +$302K 0.07% 205
2019
Q4
$373K Hold
4,800
0.03% 294
2019
Q3
$352K Hold
4,800
0.04% 300
2019
Q2
$296K Hold
4,800
0.03% 319
2019
Q1
$306K Hold
4,800
0.03% 310
2018
Q4
$245K Sell
4,800
-600
-11% -$30.6K 0.03% 330
2018
Q3
$313K Buy
+5,400
New +$313K 0.03% 316